Free Trial

Cellectis (CLLS) Short Interest Ratio & Short Volume

$2.71
0.00 (0.00%)
(As of 05/31/2024 ET)

Cellectis Short Interest Data

Current Short Interest
509,900 shares
Previous Short Interest
656,100 shares
Change Vs. Previous Month
-22.28%
Dollar Volume Sold Short
$1.57 million
Short Interest Ratio
9.9 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
55,580,000 shares
Percentage of Shares Shorted
0.92%
Today's Trading Volume
13,536 shares
Average Trading Volume
47,944 shares
Today's Volume Vs. Average
28%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cellectis ?

Sign up to receive the latest short interest report for Cellectis and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CLLS Short Interest Over Time

CLLS Days to Cover Over Time

CLLS Percentage of Float Shorted Over Time

Cellectis Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024509,900 shares $1.57 million -22.3%N/A9.9 $3.08
4/30/2024656,100 shares $1.68 million -2.5%N/A12.9 $2.56
4/15/2024672,800 shares $1.76 million -0.6%N/A17.8 $2.62
3/31/2024676,500 shares $1.79 million -0.4%N/A16.3 $2.65
3/15/2024679,300 shares $1.73 million -6.6%N/A13.5 $2.54
2/29/2024727,500 shares $1.88 million -0.1%N/A10.6 $2.58
2/15/2024728,200 shares $2.08 million -0.9%N/A8.2 $2.85
1/31/2024735,100 shares $2.21 million -4.2%N/A3.6 $3.00
1/15/2024767,300 shares $2.22 million -1.9%N/A0.4 $2.89
12/31/2023781,800 shares $2.41 million -7.0%N/A0.4 $3.08
12/15/2023840,900 shares $2.69 million -19.9%N/A0.5 $3.20
11/30/20231,050,000 shares $3.13 million -28.1%N/A0.6 $2.98
11/15/20231,460,000 shares $4.09 million +302.8%N/A0.8 $2.80
10/31/2023362,500 shares $349,450.00 -2.7%N/A0.2 $0.96
10/15/2023372,400 shares $513,912.00 +7.9%N/A6.9 $1.38
9/30/2023345,200 shares $545,416.00 +7.6%N/A5.6 $1.58
9/15/2023320,800 shares $545,360.00 -0.5%N/A6.3 $1.70
8/31/2023322,300 shares $667,161.00 -2.7%N/A6.5 $2.07
8/15/2023331,100 shares $652,267.00 -3.5%N/A6.5 $1.97
7/31/2023343,200 shares $734,448.00 +9.2%N/A5.7 $2.14
7/15/2023314,400 shares $704,287.44 +0.5%N/A5.5 $2.24
6/30/2023312,800 shares $615,434.00 -1.4%N/A6.2 $1.97
6/15/2023317,300 shares $640,946.00 +2.6%N/A5.2 $2.02
5/31/2023309,200 shares $587,480.00 -2.5%N/A4.5 $1.90
5/15/2023317,200 shares $558,272.00 +0.2%N/A4.6 $1.76
4/30/2023316,700 shares $595,396.00 -13.0%N/A3.7 $1.88
4/15/2023363,800 shares $742,152.00 -0.2%N/A3.2 $2.04
3/31/2023364,600 shares $703,678.00 -2.3%N/A2.8 $1.93
3/15/2023373,100 shares $682,773.00 +1.4%N/A2.7 $1.83
2/28/2023367,900 shares $813,059.00 -6.6%N/A2.5 $2.21
2/15/2023393,800 shares $945,120.00 +5.4%N/A2.6 $2.40
1/31/2023373,600 shares $1.14 million +34.6%N/A2.4 $3.05
1/15/2023277,600 shares $1.07 million +31.0%0.6%2.4 $3.84
12/30/2022211,900 shares $444,990.00 -32.2%0.5%1.9 $2.10
12/15/2022312,400 shares $702,900.00 -17.4%0.7%3.2 $2.25
11/30/2022378,000 shares $831,600.00 -28.2%0.8%4.5 $2.20
11/15/2022526,300 shares $1.18 million -9.3%1.2%6.3 $2.25
10/31/2022580,400 shares $1.44 million -13.9%1.3%6.9 $2.49
10/15/2022674,400 shares $1.66 million -6.7%1.5%6.5 $2.46
9/30/2022722,600 shares $1.65 million -11.8%1.6%6.6 $2.29
New trading system called MSFT, NVDA & MSFT (Ad)

Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.

Just follow this link here!
9/15/2022819,400 shares $2.61 million -2.4%1.8%7.2 $3.19
8/31/2022839,700 shares $2.78 million -2.4%1.9%6.5 $3.31
8/15/2022860,300 shares $3.51 million -3.0%1.9%6.3 $4.08
7/31/2022887,300 shares $2.32 million -9.2%2.0%6.1 $2.62
7/15/2022976,800 shares $2.40 million +1.0%2.2%6.7 $2.46
6/30/2022966,900 shares $2.74 million -4.3%2.2%6.7 $2.83
6/15/20221,010,000 shares $2.53 million -2.9%2.2%6.7 $2.50
5/31/20221,040,000 shares $3.76 million -1.9%2.3%5.2 $3.62
5/15/20221,060,000 shares $3.36 million -12.4%2.4%4.4 $3.17
4/30/20221,210,000 shares $4.24 million -24.8%2.7%4.7 $3.50
4/15/20221,610,000 shares $6.65 million -5.9%3.6%5.8 $4.13
3/31/20221,710,000 shares $7.76 million -4.5%3.8%5.5 $4.54
3/15/20221,790,000 shares $7.59 million -8.2%4.0%5.8 $4.24
2/28/20221,950,000 shares $8.83 million +18.9%4.3%6.5 $4.53
2/15/20221,640,000 shares $9.18 million +46.4%3.6%6.4 $5.60
1/31/20221,120,000 shares $6.96 million +16.7%2.5%4.6 $6.21
1/15/2022959,700 shares $7.00 million +31.4%N/A4.4 $7.29
12/31/2021730,200 shares $5.93 million +9.4%1.6%3.3 $8.12
12/15/2021667,300 shares $5.61 million -7.7%1.5%2.9 $8.41
11/30/2021722,900 shares $6.23 million +17.9%1.6%3.4 $8.62
11/15/2021613,200 shares $6.12 million +2.6%1.4%3.1 $9.98
10/29/2021597,800 shares $6.43 million -38.0%1.3%3 $10.76
10/15/2021964,500 shares $10.45 million -22.8%2.1%4.9 $10.83
9/30/20211,250,000 shares $15.76 million -1.6%2.8%6.7 $12.61
9/15/20211,270,000 shares $17.78 million +1.6%2.8%7.6 $14.00
8/31/20211,250,000 shares $17.98 million -3.9%2.8%6.7 $14.38
8/13/20211,300,000 shares $16.28 million -7.8%2.9%6.2 $12.52
7/30/20211,410,000 shares $18.26 million No Change3.1%6.5 $12.95
7/15/20211,410,000 shares $19.29 million +11.9%3.1%6.4 $13.68
6/30/20211,260,000 shares $19.49 million +5.9%2.8%5.6 $15.47
6/15/20211,190,000 shares $17.92 million -21.7%2.6%4.5 $15.06
5/28/20211,520,000 shares $23.82 million +2.7%3.4%5.4 $15.67
5/14/20211,480,000 shares $21.93 million +28.7%N/A4.5 $14.82
4/30/20211,150,000 shares $21.76 million -0.9%2.8%3.2 $18.92
4/15/20211,160,000 shares $22.63 million -5.7%2.8%2.9 $19.51
3/31/20211,230,000 shares $23.14 million +10.8%3.2%2.7 $18.81
3/15/20211,110,000 shares $22.14 million +28.1%2.9%2.4 $19.95
2/26/2021866,800 shares $17.89 million +117.8%2.2%1.7 $20.64
2/12/2021398,000 shares $10.70 million -9.3%1.0%0.9 $26.88
1/29/2021438,700 shares $12.39 million -28.6%1.0%1 $28.25
1/15/2021614,200 shares $19.00 million -21.5%1.5%1.7 $30.94
12/31/2020782,100 shares $23.00 million -10.9%1.9%2.3 $29.41
12/15/2020878,100 shares $27.41 million -3.6%2.1%3.1 $31.21
11/30/2020911,200 shares $22.06 million -10.7%2.2%4.6 $24.21
11/15/20201,020,000 shares $19.50 million +20.8%2.4%5.8 $19.12
10/30/2020844,700 shares $13.82 million +16.8%2.0%4.9 $16.36
10/15/2020723,400 shares $15.86 million +28.2%1.7%4.5 $21.92
9/30/2020564,200 shares $10.44 million -0.5%1.3%3.7 $18.50
9/15/2020567,100 shares $11.44 million +4.8%1.3%3.7 $20.18
8/31/2020540,900 shares $9.98 million +18.4%1.3%3.2 $18.45
Your $200 account credit is about to expire (Ad)

Update to MarketBeat All Access and Save $200 on Your Annual Subscription.

Start Your Risk-Free Trial Here
8/14/2020456,800 shares $7.82 million +32.1%1.1%2.4 $17.12
7/31/2020345,700 shares $5.43 million -0.1%0.8%1.6 $15.70
7/15/2020345,900 shares $6.15 million -3.7%0.8%1.6 $17.77
6/30/2020359,300 shares $6.45 million +39.9%0.9%1.7 $17.94
6/15/2020256,900 shares $4.20 million -16.9%0.6%1.2 $16.34
5/29/2020309,200 shares $5.71 million -8.0%0.7%1.6 $18.47
5/15/2020336,000 shares $6.49 million -5.8%0.8%1.9 $19.32
4/30/2020356,700 shares $4.65 million +34.4%0.8%2.4 $13.05
4/15/2020265,400 shares $2.89 million +21.2%0.6%1.8 $10.89
3/31/2020218,900 shares $2.64 million -35.3%0.5%1.6 $12.06
3/13/2020338,500 shares $3.28 million +5.7%0.8%2.6 $9.70
2/28/2020320,200 shares $2.50 million +13.0%0.8%2.3 $7.81
2/14/2020283,300 shares $3.52 million +8.2%0.7%2.2 $12.42
1/31/2020261,800 shares $4.38 million +15.4%0.6%2 $16.74
1/15/2020226,800 shares $4.02 million -7.5%0.5%1.7 $17.71
12/31/2019245,100 shares $4.02 million -22.7%0.6%2 $16.39

CLLS Short Interest - Frequently Asked Questions

What is Cellectis' current short interest?

Short interest is the volume of Cellectis shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 509,900 shares of CLLS short. Learn More on Cellectis' current short interest.

What is a good short interest ratio for Cellectis?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLLS shares currently have a short interest ratio of 10.0. Learn More on Cellectis's short interest ratio.

Which institutional investors are shorting Cellectis?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cellectis: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Cellectis' short interest increasing or decreasing?

Cellectis saw a decline in short interest in May. As of May 15th, there was short interest totaling 509,900 shares, a decline of 22.3% from the previous total of 656,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Cellectis' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cellectis: iTeos Therapeutics, Inc. (7.82%), Taysha Gene Therapies, Inc. (9.11%), Valneva SE (0.10%), Exscientia plc (3.66%), Adaptive Biotechnologies Co. (8.92%), Cabaletta Bio, Inc. (18.85%), Alector, Inc. (10.33%), Lexeo Therapeutics, Inc. (4.46%), TScan Therapeutics, Inc. (0.93%), Ocugen, Inc. (20.24%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Cellectis stock?

Short selling CLLS is an investing strategy that aims to generate trading profit from Cellectis as its price is falling. CLLS shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cellectis?

A short squeeze for Cellectis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLLS, which in turn drives the price of the stock up even further.

How often is Cellectis' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLLS, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CLLS) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners